End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
2018/19 was the first season of introduction of a newly licensed adjuvanted influenza vaccine (aTIV) for adults aged 65 years and over and the sixth season in the roll-out of a childhood influenza vaccination programme with a quadrivalent live attenuated influenza vaccine (LAIV). The season saw main...
Main Authors: | Pebody, RG, Whitaker, H, Ellis, J, Andrews, N, Marques, DFP, Cottrell, S, Reynolds, AJ, Gunson, R, Thompson, C, Galiano, M, Lackenby, A, Robertson, C, O'Doherty, MG, Owens, K, Yonova, I, Shepherd, SJ, Moore, C, Johnston, J, Donati, M, McMenamin, J, de Lusignan, S, Zambon, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2019
|
Similar Items
-
End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18
by: Pebody, R, et al.
Published: (2019) -
Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17
by: Pebody, R, et al.
Published: (2018) -
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
by: Pebody, R, et al.
Published: (2016) -
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17
by: Pebody, R, et al.
Published: (2017) -
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
by: Sinnathamby, MA, et al.
Published: (2023)